Faces of Digital Health

• How does Cleveland Clinic London invest in AI and healthcare IT?

  6% of the hospital budget, EPIC and 100 healthcare IT systems. That's the description of the infrastructure in the Cleveland clinic London. CIO Raihaan Mughal likes to emphasize CEOs are concerned about three things: 1️⃣ Increasing revenue 2️⃣ Reducing cost 3️⃣ Mitigating risk When investing, Cleveland clinic is mindful of Return on investment, return on employee. When it comes to AI, CIO Raihaan Mughal says: "Take your time, be skeptical about vendor promises." Cleveland Clinic in the US is running a pilot comparing 5 ambient solutions before they sign a long-term contract. Tune in to the full discussion with Raihaan, recorded at the Digital Health Excellence Forum by Smart Bridges GmbH in Berlin. Youtube: https://lnkd.in/dKzBrAxS www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/

  --------  

  22:03
• HIMSS Global 2025: AI is everywhere

  In early March HIMSS Global (https://www.himssconference.com/), the currently biggest global gathering about healthcare IT took place Las Vegas. A few tens of thousands of people visit HIMSS Global every year, it can take 20 minutes to get from one session to another in another building, therefor preparation and planning are key. This year, the key topic seemed to be how are companies embedding AI in their solutions. Hospital leaders talked about cybersecurity, and political uncertainty impacting the future of digital health development. I asked a few participants at HIMSS Global, who are also speaking at HIMSS Europe in Paris in June 2025, about their reflections on the content at HIMSS.  You will hear from: Guido Gunti, Chief Digital Officer at St. James Hospital, Ireland Mathew Little, Chief Nurse Information Officer (CNIO) & Associate Chief Nurse, Gloucestershire Hospital NHS Trust, UK  Rasu Shrestha, Executive Vice President, Chief Innovation & Commercialization Officer at Advocate Health, USA, Henrique Martins, Associate Professor in Health Management & Leadership, Portugal, Rachel Dunscombe, CEO of openEHR International www.facesofdigitalhealth.com https://fodh.substack.com/ https://www.youtube.com/@facesofdigitalhealth

  --------  

  18:52
• NextMed Health 2025: Agentic AI in healthcare and beyond

  This short episode will address some of the trends shaping the future of healthcare: agentic AI,  Longevity efforts, Uncertain policy in light of the current US government.  You will hear from Daniel Kraft - founder of NextMed Health - a unique interdisciplinary community dedicated to catalyzing and accelerating the arrival of a new, human-centric, technology-enabled health age.  NextMed Health is a very special event, focused on updates in biotech, policy, convergence of technology and expectations of the future. Daniel shared his views on: the expectation that the current US government will not regulate AI and how will this impact healthtech,  what will be covered around longevity and health span at NextMed ,  Innovations in the brain-mind-body connection and more. Expect updates on the conference at: Newsletter: https://fodh.substack.com/ Youtube: https://www.youtube.com/@facesofdigitalhealth Linkedin: https://www.linkedin.com/in/tjasazajc/ www.facesofdigitalhealth.com

  --------  

  15:42
• Decoding Cancer: AI, Biomarkers & Precision Medicine

  When it comes to cancer, prevalence is increasing and there is still a lot we don't understand about the factors and causes of cancers. Many studies have clearly demonstrated the benefits of biomarker testing for cancer therapy. However, broadly speaking, roughly 30% of cancer patients are eligible for targeted therapies based on their tumor profile. And even when the biomarket is present, roughly 30% of the eligible patients respond to these treatments. We have a lot more to uncover. In the discussion you are about to hear, I spoke with Luka Ausec - an expert in the field of biology and computational science. He works as the Chief discovery officer at Genialis, RNA biomarker company which develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Luka oversees internal R&D and external partner projects, with the common goal of advancing therapeutic discovery through the rigorous application of data science. Luka’s expertise in biology and computational disciplines makes him uniquely adept at innovating solutions at this nexus. He believes a successful discovery process is built on clear lines of communication and unwavering scientific integrity. In addition, Luka directs the implementation of Genialis’ products. We discussed the current state of cancer research, role of computational science in drug discovery, clinical decision support development and response predictions development in the field of cancer. Read more on cancer research and digital health in our newsletter: https://substack.com/home/post/p-78204410 Website: www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/

  --------  

  41:38
• How to Identify High-Quality Digital Health Apps: The DIME Seal Explained

  This episode of Faces of Digital Health explores how digital health solutions can be evaluated for quality and reliability. Tjasa Zajc speaks with Vice President of Digital Medicine Society (DiMe) Doug Mirsky and Boston Children’s Hospital SVP and Chief Innovation Officer John Brownstein about the DIME Seal, a certification designed to help hospitals and clinicians identify trustworthy digital health software. John discusses the challenges hospitals face in selecting and implementing digital tools, emphasizing the resource-intensive nature of evaluation. The DIME Seal aims to reduce this burden by setting a baseline quality standard across evidence, usability, privacy, security, and equity. The conversation also touches on the challenges facing digital health startups, including funding shifts, AI competition, and sustainability concerns. Doug highlights the early success of the Seal and the role it plays in helping both adopters and developers navigate the digital health landscape. The discussion closes with reflections on how digital health innovation will evolve, the role of regulatory bodies, and advice for startups in 2025’s competitive market. Newsletter: https://fodh.substack.com/ Youtube: https://www.youtube.com/watch?v=mLkyU4LulVk&t=3s Website: www.facesofdigitalhealth.com #DigitalHealth #HealthcareInnovation #HealthTech #DIMESeal #MedicalSoftware #AIinHealthcare #DigitalTherapeutics #Telemedicine #HealthIT #MedicalApps

  --------  

  35:33

Weitere Technologie Podcasts

Trending Technologie Podcasts

Über Faces of Digital Health